PHARMAC - Latest News [Page 21]
Hepatitis B treatment to take forward step
Tuesday, 31 March 2009, 1:57 pm | PHARMAC
Treatment of the potentially fatal liver disease hepatitis B is set to take a major forward step with an additional funded treatment available from 1 April 2009. More >>
Non-stimulant treatment for ADHD funded
Thursday, 19 March 2009, 10:36 am | PHARMAC
PHARMAC has approved funding for a new type of drug to treat behavioural problems in children. From 1 April 2009 atomoxetine (Strattera) will be funded for people with attention deficit hyperactivity disorder (ADHD). Available under Special Authority, ... More >>
Patient safety top of mind with acne drug decision
Friday, 19 December 2008, 12:57 pm | PHARMAC
Widening access to a medicine used to treat acne has been made with full awareness of patient safety issues, says PHARMAC’s medical director Dr Peter Moodie. More >>
PHARMAC: challenges require innovative thinkinking
Wednesday, 17 December 2008, 3:25 pm | PHARMAC
PHARMAC’s Chief Executive Matthew Brougham says many future challenges will only be addressed through new and innovative thinking, and by working better with stakeholders, particularly with prescribers, pharmacists and consumer groups. More >>
PHARMAC statement on Herceptin 12 month funding
Wednesday, 10 December 2008, 10:49 am | PHARMAC
PHARMAC has played its part in the decision to fund 12 months Herceptin and will continue to assist the government as required. PHARMAC’s role has included providing information as necessary, and assisting the Ministry of Health with its contract ... More >>
Doctors take to electronic application system
Tuesday, 2 December 2008, 3:28 pm | PHARMAC
Nearly 3000 doctors are now using an electronic system for helping patients to access some medicines. More >>
Further antipsychotic treatment gets funding tick
Monday, 1 December 2008, 12:53 pm | PHARMAC
People with schizophrenic disorders have a new funded treatment available from today. More >>
Drug company scaremongering, says Pharmac
Tuesday, 25 November 2008, 4:16 pm | PHARMAC
People can be confident a generic version of a widely-used gastrointestinal drug will work just as well as the medicine it is replacing, says PHARMAC. More >>
2008 decisions highlight funding tensions
Thursday, 16 October 2008, 10:22 am | PHARMAC
The past year has emphasised the difficult trade-offs that PHARMAC faces in allocating pharmaceutical spending, says CEO Matthew Brougham. More >>
New guidance for antipsychotic use in elderly
Tuesday, 7 October 2008, 10:11 am | PHARMAC
PHARMAC and the College of Psychiatrists have today jointly launched new guidance on the use of antipsychotic medicines in the elderly. More >>
Two newly funded treatments for prostate disease
Wednesday, 1 October 2008, 11:29 am | PHARMAC
PHARMAC is to begin funding treatments for two types of prostate disease in men - prostate cancer and benign prostatic hyperplasia (BPH). More >>
Consultation on alternative thyroid treatment
Tuesday, 30 September 2008, 2:21 pm | PHARMAC
PHARMAC has begun consultation on a proposal to subsidise a further brand of the thyroid treatment levothyroxine. Consultation is a further step towards introducing an alternative to the Eltroxin brand that is currently funded. More >>
Increased condoms range a win-win
Thursday, 21 August 2008, 12:51 am | PHARMAC
Funding a wider range of condoms saves taxpayers money, increases choice and promotes better sexual health practices, PHARMAC says. Responding to comments on its decision to fund a wider range of condoms including textured, coloured and flavoured condoms, ... More >>
Once-a-day treatment for ADHD funded
Tuesday, 19 August 2008, 2:55 pm | PHARMAC
A once-a-day treatment for people with ADHD, (Attention Deficit Hyperactivity Disorder) is being funded from 1 September. More >>
Once-a-day treatment for ADHD funded
Tuesday, 19 August 2008, 2:26 pm | PHARMAC
A once-a-day treatment for people with ADHD, (Attention Deficit Hyperactivity Disorder) is being funded from 1 September. More >>
New treatment option for persistent migraines
Monday, 18 August 2008, 9:34 am | PHARMAC
People having trouble controlling persistent migraines will have a new treatment option from 1 September. More >>
PHARMAC funds new treatment for skin cancers
Wednesday, 13 August 2008, 2:18 pm | PHARMAC
A new treatment is being funded for people with a generally non-malignant form of skin cancer. More >>
PHARMAC reaffirms confidence in 9 week treatment
Thursday, 7 August 2008, 3:07 pm | PHARMAC
After extensive investigation, PHARMAC has declined an application from the pharmaceutical company Roche to fund 12 month treatments with the breast cancer drug Herceptin, but will continue to fully fund the 9 week treatment. More >>
Medicine funding up $17 million
Friday, 18 July 2008, 10:42 am | PHARMAC
The Minister of Health has approved an increased community pharmaceuticals budget for the 2008/09 financial year. The budget of $653 million represents a $17 million increase on 2007/08. More >>
Calls for comment on advisory committee guidelines
Tuesday, 20 May 2008, 10:13 am | PHARMAC
PHARMAC is reviewing the guidelines under which its main clinical advisory committee operates. The Pharmacology and Therapeutics Advisory Committee (PTAC) is a statutory committee that provides advice to the Government drug-funding agency. More >>
